Legal Representation
Attorney
Lisa C. Pavento
USPTO Deadlines
Next Deadline
1986 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-31)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 31, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Dec 31, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 23, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 1, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 24, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 24, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 24, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 24, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 13, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Sep 13, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 13, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 26, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Feb 8, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 8, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 8, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Feb 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 31, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 31, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 9, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposes, namely, reagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical purposes; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
Class 009
DNA analysis apparatus, namely, medical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; RNA analysis apparatus, namely, medical laboratory research instruments for RNA analysis; RNA sequencing devices, namely, laboratory devices for detecting genetic sequences; RNA chips; genome analyzer machines, namely, laboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispensed, namely, dispensers for measuring and dispensing of distilled water, not for medical use; incubators for cell culture, not for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatus, namely, laboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing genes, namely, laboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNA, MRNA, and DNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatus, namely, laboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatus, namely, DNA chips; diagnostic chips for analyzing blood plasma laboratory apparatus, namely, DNA chips
Class 042
RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to science, namely, scientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicines, namely, conducting clinical trials for others; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image data, namely, engineering services; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing services; providing scientific information on the testing, inspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical trials, namely, conducting clinical trials for others; providing temporary use of online, non-downloadable computer operating software for genome analyzer machines
Additional Information
Pseudo Mark
MRN ADVANCE
Classification
International Classes
005
009
042